Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Автори: | , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Conference item |
Мова: | English |
Опубліковано: |
American Society of Tropical Medicine and Hygiene
2019
|